retatrutide clinical trial south africa Noteworthy Focus Points That Help Differentiate Anti-Obesity Drug Development Strategies in a Rapidly Evolving and Expanding R&D Landscape Public health threat as South

Clinical studies have shown that Wegovy, a different dosage of semaglutide, the drug found in Ozempic and Rybelsus, is effective in lowering the risk of cardiovascular events in those who are overweight or obese

Petrovic et al., 2006

Proven alternatives deliver comparable results with established safety: tirzepatide monotherapy produces 15-22% weight loss with FDA approval and extensive clinical data, while CagriSema (cagrilintide + semaglutide) delivers 15-25% weight loss with Phase 3 trial validation and clearer path to medical acceptance

it supports the bodys own GLP-1 production

L.YangZ.et al (2022)

Whats more, this platform is very budget-friendly as far as GLP-1 providers go